Gavril Pasternak Websites
Welcome to the Emerging Solutions in Pain
Emerging Solutions in Pain - Today's source for tomorrow's pain management
5,548,502
$
240.00
Sparian Biosciences
Sparian Biosciences is an early stage pharmaceutical company whose first program focuses on a novel class of agents, the arylepoxamides, which selectively bind to a newly discovered receptor to produce analgesia with no side effects
Not Applicable
$
8.95
Sparian Biosciences
Sparian Biosciences is an early stage pharmaceutical company whose first program focuses on a novel class of agents, the arylepoxamides, which selectively bind to a newly discovered receptor to produce analgesia with no side effects
Not Applicable
$
8.95
Sparian Biosciences
Sparian Biosciences is an early stage pharmaceutical company whose first program focuses on a novel class of agents, the arylepoxamides, which selectively bind to a newly discovered receptor to produce analgesia with no side effects
Not Applicable
$
8.95
